Skip to main content
Premium Trial:

Request an Annual Quote

Geospiza Deploys New Finch Oligo Order Manager at Johns Hopkins

NEW YORK, March 31 (GenomeWeb News) -Geospiza of Seattle said today it has successfully deployed its new Finch Oligo Order Manager, an add-on module to its DNA sequencing data management system, at Johns Hopkins University's Genetic Resources Core Facility.

 

This software adds on oligonucleotide management, order order placement, and order fulfillment capabilities to Geospiza's Finch Sequencing Center. It includes the ability to enter sequences, track orders, and incorporate contact information in the system.

 

The Scan

Drug Response Variants May Be Distinct in Somatic, Germline Samples

Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.

Breast Cancer Risk Gene Candidates Found by Multi-Ancestry Low-Frequency Variant Analysis

Researchers narrowed in on new and known risk gene candidates with variant profiles for almost 83,500 individuals with breast cancer and 59,199 unaffected controls in Genome Medicine.

Health-Related Quality of Life Gets Boost After Microbiome-Based Treatment for Recurrent C. Diff

A secondary analysis of Phase 3 clinical trial data in JAMA Network Open suggests an investigational oral microbiome-based drug may lead to enhanced quality of life measures.

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.